Search
for
Sort by
Research 121–150 of 786
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- The Role of Janus Kinase Inhibitors in Dermatology
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- The role of lymphocytes in the development and treatment of alopecia areata
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Ritlecitinib: First Approval
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Pharmacotherapy of alopecia areata
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Novel therapies for alopecia areata: The era of rational drug development